Return to Answers From the Lab

Better Testing for Bleeding Disorders

By Samantha Rossi • July 23, 2026
Related Episodes
Lab Outreach Delivers Value, Growth, and Strategic Advantage

By Samantha Rossi • July 9, 2026
Personalized Therapy Growth Driven by Clinical Diagnostics

By Samantha Rossi • June 25, 2026
How Pharmacogenomics Deliver More Precise Cancer Therapy

By Samantha Rossi • June 11, 2026

Samantha Rossi

Samantha Rossi is a Digital Marketing Manager at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.

Related Posts

Featured new tests in quarter two of 2026
July 24, 2026

In the second quarter of 2026, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.
Better Testing for Bleeding Disorders featured image
Better Testing for Bleeding Disorders
July 23, 2026

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss the Protecting Access to Medicare Act (PAMA) and a recent Cyclospora outbreak making headlines. Later, Dr. Pritt welcomes Juliana Perez Botero, M.D., a Mayo Clinic hematologist, to explore innovative testing approaches for bleeding disorders.
Expanding access through strategic collaboration: A Q&A with Mary Jo Williamson featured image
Expanding access through strategic collaboration: A Q&A with Mary Jo Williamson
July 22, 2026

As innovation in clinical diagnostics accelerates, collaboration is becoming increasingly essential to ensure new tools reach the clinicians and patients who need them most. Mary Jo Williamson, chief administrative officer at Mayo Clinic Laboratories, discusses how a strategic approach to collaboration is helping build a more connected diagnostic ecosystem and enabling more comprehensive care.